Literature DB >> 28190437

Neurology of cardiopulmonary resuscitation.

M Mulder1, R G Geocadin2.   

Abstract

This chapter aims to provide an up-to-date review of the science and clinical practice pertaining to neurologic injury after successful cardiopulmonary resuscitation. The past two decades have seen a major shift in the science and practice of cardiopulmonary resuscitation, with a major emphasis on postresuscitation neurologic care. This chapter provides a nuanced and thoughtful historic and bench-to-bedside overview of the neurologic aspects of cardiopulmonary resuscitation. A particular emphasis is made on the anatomy and pathophysiology of hypoxic-ischemic encephalopathy, up-to-date management of survivors of cardiopulmonary resuscitation, and a careful discussion on neurologic outcome prediction. Guidance to practice evidence-based clinical care when able and thoughtful, pragmatic suggestions for care where evidence is lacking are also provided. This chapter serves as both a useful clinical guide and an updated, thorough, and state-of-the-art reference on the topic for advanced students and experienced practitioners in the field.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  cardiac arrest; hypoxic-ischemic encephalopathy; neurologic prognostication; post cardiac arrest syndrome; targeted temperature management; therapeutic hypothermia

Mesh:

Year:  2017        PMID: 28190437     DOI: 10.1016/B978-0-444-63599-0.00032-6

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

1.  Pupil Reactivity in Refractory Out-of-Hospital Cardiac Arrest Treated by Extra-Corporeal Cardiopulmonary Resuscitation.

Authors:  Romain Jouffroy; Anastasia Saade; Pascal Philippe; Alexandra Guyard; Pierre Carli; Benoit Vivien
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-09-24

Review 2.  Lance Adams syndrome: two cases report and literature review.

Authors:  Yu Guo; Yan Xiao; Li-Fa Chen; De-Hui Yin; Ruo-Dan Wang
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.